Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.JzBkOQ-g.js ...

Estee Lauder on Tuesday expanded a restructuring plan that would now involve up to 7,000 job cuts as the cosmetics giant ...

WESTLAKE VILLAGE, Calif., Feb. 03, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, ...

His tenure at Amgen included roles in sales and marketing ... “Brian is an accomplished industry professional with a strong background in hematology and oncology, and he is ideally suited ...

A distinguished technology leader, Phanindra Kankanampati has established himself as an expert in procurement technology and digital transformation.

In Novartis Pharms. Corp. v. Torrent Pharma Inc., the U. S. Court of Appeals for the Federal Circuit shut down efforts to ...

CARE Pharmacies appointed Ryan Hollingsworth, Natalie Ryan and Steven Pieri to its 2025 board of directors, and Lionel ...

Akero Therapeutics, Inc.’s AKRO share price has surged by 97.52%, which has investors questioning if this is right time to ...

Median duration of therapy was 20.5 months for the combination and 16.4 months with single-agent nivolumab. Median number of ...

From medical devices to OTC drugs, preemption to expert preclusion, New York state and federal courts issued decisions in ...

WESTLAKE VILLAGE, Calif. - Genelux Corporation (NASDAQ: GNLX), an immuno-oncology company in the late clinical stage with a market capitalization of $135 million, announced the appointment of Matthew ...

Meanwhile, Dr. Manuel López-Figueroa and Dr. Carlos Buesa will remain on the Board, subject to a positive vote by the ...